Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2009-07-13
2011-10-25
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C530S387900, C530S388220
Reexamination Certificate
active
08043617
ABSTRACT:
A human antibody or an antigen-binding fragment which binds human IL-6 receptor (hIL-6R) with a KDof about 500 pM or less and blocks IL-6 activity with an IC50of 200 pM or less. In preferred embodiments, the antibody the antibody or antigen-binding fragment binds hIL-6R with an affinity at least 2-fold higher relative to its binding monkey IL-6R.
REFERENCES:
patent: 5480796 (1996-01-01), Kishimoto
patent: 5670373 (1997-09-01), Kishimoto
patent: 5795965 (1998-08-01), Tsuchiya
patent: 5817790 (1998-10-01), Tsuchiya
patent: 5888510 (1999-03-01), Kishimoto
patent: 5888511 (1999-03-01), Skurkovich et al.
patent: 6086874 (2000-07-01), Yoshida et al.
patent: 6261560 (2001-07-01), Tsujinaka et al.
patent: 6410691 (2002-06-01), Kishimoto
patent: 6692742 (2004-02-01), Nakamura et al.
patent: 6723319 (2004-04-01), Ito et al.
patent: 7320792 (2008-01-01), Ito et al.
patent: 2002/0187150 (2002-12-01), Mihara et al.
patent: 2004/0071706 (2004-04-01), Ito et al.
patent: 2004/0219156 (2004-11-01), Goldenberg et al.
patent: 2005/0142635 (2005-06-01), Tsuchiya
patent: 2005/0238644 (2005-10-01), Mihara et al.
patent: 2006/0078531 (2006-04-01), Sota
patent: 2006/0078532 (2006-04-01), Omoigui
patent: 2006/0078533 (2006-04-01), Omoigui
patent: 2006/0177436 (2006-08-01), Ghilardi et al.
patent: 2006/0251653 (2006-11-01), Okuda et al.
patent: 2006/0275294 (2006-12-01), Omoigui
patent: 2006/0292147 (2006-12-01), Yoshizaki et al.
patent: 2007/0036785 (2007-02-01), Kishimoto et al.
patent: 2007/0036788 (2007-02-01), Sheriff et al.
patent: 2007/0098714 (2007-05-01), Nishimoto et al.
patent: 2007/0148169 (2007-06-01), Yoshizaki et al.
patent: 2007/0280945 (2007-12-01), Stevens et al.
patent: 2008/0124325 (2008-05-01), Ito et al.
patent: 2008/0145367 (2008-06-01), Bove et al.
patent: 0 628 639 (1994-12-01), None
patent: 0409607 (1996-10-01), None
patent: 0 783 893 (1997-07-01), None
patent: 0 800 829 (1997-10-01), None
patent: 0 811 384 (1997-12-01), None
patent: 0 628 639 (1999-06-01), None
patent: 0 923 941 (1999-06-01), None
patent: 1 004 315 (2000-05-01), None
patent: 1 074 268 (2001-02-01), None
patent: 1 108 435 (2001-06-01), None
patent: 1 314 437 (2003-05-01), None
patent: 1 327 681 (2003-07-01), None
patent: 1 334 731 (2003-08-01), None
patent: 1 475 100 (2004-11-01), None
patent: 1 475 101 (2004-11-01), None
patent: 0 413 908 (2005-08-01), None
patent: 0 923 941 (2006-05-01), None
patent: 0 811 384 (2006-06-01), None
patent: 1 108 435 (2007-01-01), None
patent: 1 810 980 (2007-07-01), None
patent: 1 074 268 (2008-01-01), None
patent: 1 334 731 (2008-02-01), None
patent: 1 004 315 (2008-05-01), None
patent: 2694767 (1994-02-01), None
patent: WO 95/09873 (1995-04-01), None
patent: WO 2004/096273 (2004-11-01), None
patent: WO 2005/028514 (2005-03-01), None
patent: WO 2007/143168 (2007-12-01), None
patent: WO 2008/020079 (2008-02-01), None
patent: WO 2008/049897 (2008-05-01), None
patent: WO 2008/145142 (2008-12-01), None
patent: WO 2009/095489 (2009-08-01), None
patent: WO 2009/109584 (2009-09-01), None
Mihara et al. 2005. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. International Immunopharmacology 5:1731-1740.
Paul-Pletzer. 2006. Tocilizumab: Blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders. Drugs of Today 42(9): 559-576.
Chen Gang
Fairhurst Jeanette L.
Fandl James P.
Huang Tammy T.
Karow Margaret
Cottingham, Esq. Frank R.
Gregg, Esq. Valeta
Mertz Prema
Regeneron Pharmaceuticals Inc.
LandOfFree
Human antibodies to human IL-6 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human antibodies to human IL-6 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human antibodies to human IL-6 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4288281